Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
August 26, 2019
Gene-modified cells in the brain
From the Kiem Lab, Clinical Research Division
“Exciting” but early results in trial of immunotherapy for myeloma
Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease
Understanding the genetics of X chromosome inactivation
from the Bedalov lab, Clinical Research Division
Molecular mechanisms of late cancer relapse
from the Chapuis lab, Clinical Research Division
Revealing a new way that cancer can evade immunotherapy — and, maybe, how to stop it
How a new technology solved a mystery and honors one man’s legacy
Taking the shortcut to frontline treatment
From Dr. Schmitt and the Radich lab, Clinical Research Division
The prized fraction of Fanconi Anemia
from the Adair lab and the Kiem lab, Clinical Research Division
Taking the good out of viruses to cure immunodeficiencies by in vivo gene therapy
from the Kiem lab, Clinical Research Division
Esophageal adenocarcinoma: when DNA methylation informs the treatment
from the Grady lab, Clinical Research Division
The legacy of a pioneering transplant immunologist
‘So much to be learned’: Dr. John Hansen reflects on the lives he’s saved and the answers still to come
Personalized medicine for head and neck cancer
from the Mendez lab, Clinical Research Division, and Kemp lab, Human Biology Division
Deciphering tumor diversity at the single cell level
from the Radich lab, Clinical Research Division
A master regulator to avoid ischemia tissue injury
- from the Zager's lab, Clinical Research Division
Machine learning provides new insights into tumor suppression
Algorithm illuminated surprising metabolic effects of important cancer gene
Unlocking a new path for cystine-dense peptides
From the Olson Lab, Clinical Research Division and the Strong Lab, Basic Sciences and Vaccine and Infectious Disease Divisions
AZD1775, a boost for platinum-based chemotherapy
From the Mendez Lab and Dr. Laura Chow, Clinical Research Division
The hidden function of anti-tumoral drug Motolimod to target immunosuppressive cells
from Dr. Nora Disis, Clinical Research Division
MERGE improves precision medicine for acute myeloid leukemia
from Dr. Pamela Becker, Clinical Research Division
Jump-starting innovative projects exploring pathogen-associated cancers
Pathogen-Associated Malignancies Integrated Research Center awards first round of pilot funding supporting researchers studying H. pylori, EBV and the microbiome
BCR or biomarker?
From the Warren laboratory, Clinical Research Division and Vaccine and Infectious Disease Division
Lobular breast cancer comes into the research spotlight
Research collaborations, patient advocates push to explore ‘sneaky,’ understudied subtype’s standing as a distinct disease
Hutch community mourns Robert W. Day
As president and director for 16 years, Day led Fred Hutch's 'momentous' move to South Lake Union
Unleashing T cells for adoptive immunotherapy
from the Greenberg lab, Clinical Research Division
HA-1 immunotherapy for hematopoietic stem cell transplant patients to lower leukemia relapse
from the Bleakley lab, Clinical Research Division